TONIX PHARMACEUTICALS HOLDIN (TNXP) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:TNXP • US8902608392

16.24 USD
-0.92 (-5.36%)
At close: Feb 4, 2026
16.41 USD
+0.17 (+1.05%)
After Hours: 2/4/2026, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
TNXP revenue by date.TNXP revenue by date.
7.768M10.094M
29.94%
10.801M
7.00%
88.36M
718.07%
91.666M
3.74%
112.94M
23.21%
EBITDA
YoY % growth
TNXP ebitda by date.TNXP ebitda by date.
-110.84M
-20.14%
-114.089M
-2.93%
-74.323M
34.86%
N/AN/AN/AN/A
EBIT
YoY % growth
TNXP ebit by date.TNXP ebit by date.
-112.09M
-21.43%
-118.38M
-5.61%
-77.744M
34.33%
-115.065M
-48.00%
-122.399M
-6.37%
-72.392M
40.86%
-67.571M
6.66%
Operating Margin
TNXP operating margin by date.TNXP operating margin by date.
N/A-1,523.94%-770.20%-1,065.31%-138.52%-78.97%-59.83%
EPS
YoY % growth
TNXP eps by date.TNXP eps by date.
-81,400.00
51.08%
-27,584.00
66.11%
-2,536.77
90.80%
-13.62
99.46%
-7.54
44.63%
-1.10
85.40%
-2.14
-94.44%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-3.25
66.70%
-2.65
6.62%
-2.30
40.54%
-1.92
46.58%
-1.31
59.87%
Revenue
Q2Q % growth
3.026M
17.20%
22.338M
819.64%
37.842M
1,793.99%
58.344M
1,673.37%
88.944M
2,839.33%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-36.108M
-60.62%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-3.59
84.39%
-3.660.071.82%
Q2 2025
Q2Q % growth
-3.86
99.80%
-3.28-0.58-17.71%
Q1 2025
Q2Q % growth
-2.84
99.51%
-3.290.4513.80%
Q4 2024
Q2Q % growth
-9.77
99.64%
-394.86385.0997.53%
Q3 2024
Q2Q % growth
-23.00
99.61%
-299.20276.2092.31%
Q2 2024
Q2Q % growth
-1,928.00
77.52%
-333.88-1,594.12-477.45%
Q1 2024
Q2Q % growth
-576.00
94.46%
-1,272.96696.9654.75%
Q4 2023
Q2Q % growth
-2,752.00
75.43%
-5,363.832,611.8348.69%
Q3 2023
Q2Q % growth
-5,856.00
57.57%
-4,863.36-992.64-20.41%
Q2 2023
Q2Q % growth
-8,576.00
64.85%
-8,992.32416.324.63%
Q1 2023
Q2Q % growth
-10,400.00
67.50%
-9,894.00-506.00-5.11%
Q4 2022
Q2Q % growth
-11,200.00
75.00%
-17,544.006,344.0036.16%
Q3 2022
Q2Q % growth
-13,800.00
56.88%
-20,808.007,008.0033.68%
Q2 2022
Q2Q % growth
-24,400.00
45.54%
-29,478.005,078.0017.23%
Q1 2022
Q2Q % growth
-32,000.00
28.57%
-30,466.18-1,533.82-5.03%
Q4 2021
Q2Q % growth
-44,800.00
30.00%
-39,168.00-5,632.00-14.38%
Q3 2021
Q2Q % growth
-32,000.00
44.44%
-45,696.0013,696.0029.97%
Q2 2021
Q2Q % growth
-44,800.00
69.57%
-42,432.00-2,368.00-5.58%
Q1 2021
Q2Q % growth
-44,800.00
76.67%
-35,904.00-8,896.00-24.78%
Q4 2020
Q2Q % growth
-64,000.00 -48,960.00-15,040.00-30.72%
Q3 2020
Q2Q % growth
-57,600.00 -71,808.0014,208.0019.79%
Q2 2020
Q2Q % growth
-147,200.00 -146,880.00-320.00-0.22%
Q1 2020
Q2Q % growth
-192,000.00 -205,632.0013,632.006.63%
TNXP Yearly EPS VS EstimatesTNXP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -500M -1B -1.5B
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
3.29M
16.58%
3.162M128K4.05%
Q2 2025
Q2Q % growth
1.998M
-9.51%
2.482M-484K-19.50%
Q1 2025
Q2Q % growth
2.429M
-2.14%
2.601M-172K-6.61%
Q4 2024
Q2Q % growth
2.582M
-31.68%
3.57M-988K-27.68%
Q3 2024
Q2Q % growth
2.822M
-29.26%
3.145M-323K-10.27%
Q2 2024
Q2Q % growth
2.208M 3.57M-1.362M-38.15%
Q1 2024
Q2Q % growth
2.482M 3.876M-1.394M-35.96%
Q4 2023
Q2Q % growth
3.779M 3.91M-131K-3.35%
Q3 2023
Q2Q % growth
3.989M 5.916M-1.927M-32.57%
TNXP Yearly Revenue VS EstimatesTNXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.95% 23.59% 2.7% -1.73%
Revenue2.89% -17.97% 3.93% -6.78%